Sign in

CIK 0001799191 · Accelerated filer<br>Smaller reporting company

Starling Oncology, Inc.

Sign in to watch
Tickers
STLN DFPH
Exchange
Nasdaq, OTC
Industry
Services-Offices & Clinics of Doctors of Medicine
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
843562323
Phone
562-735-3226
Business address
18000 STUDEBAKER RD, SUITE 800, CERRITOS, CA, 90703
Former names
Oncology Institute, Inc., DFP HEALTHCARE ACQUISITIONS CORP.

Securities

  • STLN Common Stock Nasdaq
  • STLNW Warrant Nasdaq
  • DFPH Common stock OTC
  1. 4 Grant or award Director acquired 91,049 shares (grant or award)
  2. 4 Grant or award Director acquired 83,333 shares (grant or award)
  3. 4 Grant or award Director acquired 84,877 shares (grant or award)
  4. 4 Grant or award Director acquired 81,790 shares (grant or award)
  5. 4 Grant or award Director acquired 74,074 shares (grant or award)
  6. 4 Open-market sale Director sold 50,000 shares at $4.00 ($200,000)
  7. 4 Other acquisition Director acquired 141,149 shares (other)
  8. 4 Other disposition Director disposed of 3,090,892 shares (other)
  9. SCHEDULE 13D/A Stake Beneficial Ownership Report
  10. 4 Grant or award Chief Executive Officer acquired 6,464 shares (grant or award)
  11. 4 Grant or award Chief Medical Officer acquired 2,086 shares (grant or award)
  12. 4 Grant or award Chief Financial Officer acquired 195 shares (grant or award)
  13. 144 Insider Sale of Securities
  14. 4 Grant or award Chief Executive Officer acquired 6,211 shares (grant or award)
  15. 4 Grant or award Chief Medical Officer acquired 1,508 shares (grant or award)
  16. 8-K Event Regulation FD disclosure
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations
  19. 8-K Event Regulation FD disclosure
  20. SCHEDULE 13D/A Stake Beneficial Ownership Report

Page 5 of 28 · 548 filings